… Adherence to anti-osteoporosis medications is poor. We carried out a cohort study using
a real-world population database to estimate the persistence of anti-osteoporosis drugs. …

… Our incident hip fracture cohort represents the most devastating type of osteoporotic … , within
cohort members, it may have helped mitigate the potential confounding due to osteoporosis …

Ocular inflammatory reactions have been described in patients on bisphosphonate treatment.
We estimated the incidence rate of ocular inflammation at 3 and 12 months in patients …

… cohort analysis to evaluate the association between osteoporosis and dementia in
Taiwan. … Patients with dementia are less likely to receive osteoporosis medication, such as …

… anti‐osteoporosis treatment with women who initiated anti‐osteoporosis medication but did
not … We performed a propensity score (PS)‐matched cohort analysis from a routine clinical …

… diabetes medications and the risk of osteoporotic fractures … conditions were analyzed:
diagnosis records of osteoporosis, … records of osteoporosis medication and diabetes medication. …

… , for the treatment of postmenopausal osteoporosis to reduce vertebral and hip fractures [1], …
risk of VTE among users of other anti-osteoporosis medication (AOM). Increased risks of VTE …

… with naïve osteoporosis medication, and those without recent fractures or lifestyle record. …
or obesity, or naïve osteoporosis medication might be describing patients with less severe …

… (2012) GRAND: the German retrospective cohort analysis on compliance and persistence
and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. …

… a retrospective cohort study to analyze the persistence to … analyzed according to the type
of antiosteoporotic drug. To avoid underestimating true persistence, switching of medications …